Alan Sebulsky insider trades: Parabilis Medicines (PBLS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Alan reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | PBLS | ↑ Buy | 17,500 | $27.06 | $474K | By Apothecary Capital LLC | Jun 16, 2026 (1d) |
| Jun 11, 2026 | PBLS | ↑ Buy | 12,500 | $20.00 | $250K | By Apothecary Capital LLC | Jun 15, 2026 (4d) |
| Mar 9, 2012 | JAZZ | ↓ Sell | 31,166 | $49.56 | $1.5M | Direct | Mar 13, 2012 (4d) |
| Nov 13, 2009 | JAZZ | ↑ Buy | 9,788 | $6.84 | $67K | Direct | Nov 17, 2009 (4d) |
| Jun 7, 2007 | JAZZ | ↑ Buy | 5,212 | $17.30 | $90K | Direct | Jun 8, 2007 (1d) |
| Apr 17, 2006 | ARRO | ↓ Sell | 10,000 | $30.50 | $305K | Direct | Apr 17, 2006 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PBLS insiders
Open-market trades in the last 12 months
About Alan Sebulsky's insider trades
Alan Sebulsky is an insider at Parabilis Medicines (PBLS). Since Apr 17, 2006, Alan has reported 4 open-market purchases worth $881K and 2 sales worth $1.8M on SEC Form 4. In the last 12 months: 2 buys ($724K).
Their filings also include grants and awards (12 filings), option exercises (3 filings), shares returned to the company (2 filings), shares withheld for taxes (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PBLS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.